Wednesday, April 20, 2022

A dangerous delay: Why it can take years to diagnose life-threatening rare diseases

Researchers from Osaka University reveal the experiences of patients who waited years to be diagnosed with a potentially life-threatening rare disease, highlighting the need to raise the awareness of rare diseases

Peer-Reviewed Publication

OSAKA UNIVERSITY

Fig.1 

IMAGE: DIAGRAM ILLUSTRATING PROBLEMS LEADING TO DELAYED DIAGNOSIS OF RARE DISEASES view more 

CREDIT: 2022 M. ISONO ET AL. WHY DOES IT TAKE SO LONG FOR RARE DISEASE PATIENTS TO GET AN ACCURATE DIAGNOSIS?—A QUALITATIVE INVESTIGATION OF PATIENT EXPERIENCES OF HEREDITARY ANGIOEDEMA. PLOS ONE

Osaka, Japan – Regular episodes of severe pains in the abdomen and mysterious swellings had become the new normal for Yuki - for 20 years. Finally, she was diagnosed with a rare disease, hereditary angioedema (HAE), and given a specialized treatment that brought much-needed relief. But what happened during those years of delay, and why did it take so long? In a study published in PLOS ONE, researchers from Osaka University revealed the experiences of patients with a rare disease who remained undiagnosed for many years. The findings highlight the importance of raising patients’ and clinicians’ awareness of rare diseases.

“There are around ten thousand rare diseases,” says lead author of the study, Moeko Isono. “Altogether, they affect over four hundred million people. There are many people who struggle to find the right diagnosis, and in certain cases the failure to do so can be fatal.”

Previous studies that looked at diagnostic delays for rare diseases usually focused on the time taken to reach a diagnosis, and other measures that can be quantified.

“For our study, we used a qualitative approach,” says Isono. “This meant that we could explore why the delays were so long and how the correct diagnosis was finally achieved. We hoped to identify areas that could be improved.”

The research team focused on patients with hereditary angioedema, a disease that typically involves long diagnostic delays. The condition causes swelling in different parts of the body, such as the skin and digestive system. It can be life-threatening if the swelling affects the airways. An accurate diagnosis is important, as the mortality rate is around three times higher if left undiagnosed.

Interviews were conducted with nine patients with the disease who had remained undiagnosed for more than five years. Patients were invited to share their experiences from initial symptoms to diagnosis with HAE. The responses revealed that many patients had become resigned to living with the symptoms and had stopped trying to find a cause.

“What was striking was that, in most cases, the possibility of a rare disease was simply not considered,” says senior author Kazuto Kato. “Symptoms were sometimes put down to ‘psychological stress’ or ‘stomach flu’ and left at that. This is concerning, because the condition needs to be treated so as to avoid worst-case scenarios and improve patients’ quality of life.”

Kato believes that raising the awareness of rare diseases is key to improving the diagnostic delays. “It’s important that the possibility of a rare disease is considered, both by clinicians and by patients. Our findings strongly suggest the need for measures to make it easier for patients and health care providers to recognize the possibility of rare diseases. For example, all clinicians should be trained to be able to realize the possibility of rare disease. Additionally, raising awareness among the public by mass media or other stakeholders is important. Health care providers sometimes cannot be fully aware of their patient’s overall condition, so patients should be encouraged to raise their suspicion and act themselves. This could reduce the diagnostic delays.”

Note: The patient’s name has been changed for reasons of confidentiality.

###

The article, “Why does it take so long for rare disease patients to get an accurate diagnosis?—A qualitative investigation of patient experiences of hereditary angioedema,” was published in PLOS ONE at DOI: https://doi.org/10.1371/journal.pone.0265847

 

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world, being named Japan's most innovative university in 2015 (Reuters 2015 Top 100) and one of the most innovative institutions in the world in 2017 (Innovative Universities and the Nature Index Innovation 2017). Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.

Website: https://resou.osaka-u.ac.jp/en

No comments: